Press release
Radionuclide Drug Conjugates (RDCs) Market Top Companies Study - Telix Pharmaceuticals Limited, Grand Pharma, Bayer AG, Novartis AG, Lantheus.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Radionuclide Drug Conjugates (RDCs) Market Size, Share & Trends Analysis Report By Type (Antibody Radionuclide Conjugates (ARC), Peptide Radionuclide Conjugates (PRC), Small Molecular Radionuclide Conjugates (SMRC)), Disease Indication (Neuroendocrine Tumors, Prostate Cancer, Renal Cell, Carcinoma, Others)- Market Outlook And Industry Analysis 2031"The Global Radionuclide Drug Conjugates (RDCs) Market is expected to grow with a CAGR of 13.9% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2567
Radionuclide Drug Conjugates (RDCs) are an innovative class of targeted cancer therapies that deliver radiation directly to tumor cells, minimizing damage to healthy tissue. Comprising four key components-a radionuclide, a targeting molecule (such as a peptide or antibody), a chelator, and a linker-RDCs offer significant advantages over traditional radiotherapy and other cancer treatments. They can effectively bypass drug resistance by directly damaging DNA with radiation, utilize molecular imaging for precise tumor localization, and integrate diagnostic and therapeutic functions by employing different radionuclides for imaging and treatment.
RDCs are primarily utilized in treating various cancers, including neuroendocrine tumors, prostate cancer, and renal cell carcinoma. Among these, the neuroendocrine tumors segment is experiencing the fastest growth, driven by a high unmet need, promising clinical results, and rapid market expansion. The significance of RDCs lies in their ability to provide effective, personalized cancer treatment with minimal side effects, making them an attractive option for patients who have exhausted other therapies or are intolerant to conventional treatments. As this emerging field develops, RDCs hold the potential to revolutionize cancer care.
List of Prominent Players in the Radionuclide Drug Conjugates (RDCs) Market:
• Telix Pharmaceuticals Limited
• Grand Pharma
• Bayer AG
• Novartis AG
• Lantheus
• Curium Pharma
• Yantai Lannacheng Biotechnology Co., Ltd
• BoomRay Pharmaceuticals
• Hengrui Medicine
• Yunnan Baiyao Group
• Sinotau
• SmartNuclide Biopharma
• Yuanda Pharmaceutical
• Other Prominent Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
The global demand for Radionuclide Drug Conjugates (RDCs) is increasing in the treatment of neuroendocrine tumors, prostate cancer, and renal cell carcinoma, driven by the growing prevalence of cancer and the need for effective targeted therapies. Technological advancements have led to the development of novel RDCs that utilize small molecules and peptides as targeting ligands, yielding promising clinical results, particularly with therapies like Novartis' Lutathera and 177Lu-PSMA-617, which have significantly improved patient outcomes in trials. This trend is boosted by the high adoption of innovative cancer treatments in North America, supported by major pharmaceutical companies such as Novartis, Lantheus, and Curium Pharma, alongside robust healthcare infrastructure and favorable reimbursement policies in developed regions. The increasing unmet need for effective treatments, especially for rapidly growing neuroendocrine tumors, further underscores the potential for RDCs in modern cancer care.
Challenges:
The Radionuclide Drug Conjugates (RDC) market faces intense competition from other targeted cancer therapies and traditional treatments, necessitating continuous innovation to keep pace with rapidly evolving technologies. To capture market share, RDCs must demonstrate superior efficacy and safety compared to existing therapies, while also navigating high development costs and regulatory hurdles associated with lengthy approval processes for new radiopharmaceuticals. Additionally, reimbursement challenges require proving cost-effectiveness to payers, adding further complexity to market entry and sustainability.
Regional Trends:
North America leads the Radionuclide Drug Conjugates (RDC) market due to a robust product pipeline and increased regulatory approvals for targeted cancer therapies, fostering a favorable environment for research and development. The region, particularly the US, has a high adoption rate for innovative cancer treatments, a trend expected to continue with RDCs. The presence of major pharmaceutical companies like Novartis, Lantheus, and Curium Pharma further strengthens this leadership, supported by a well-developed healthcare infrastructure that facilitates the commercialization of novel therapies. Additionally, the growing prevalence of cancers such as neuroendocrine tumors and prostate cancer, coupled with a significant unmet need for effective treatments, drives demand for RDCs. Favorable reimbursement policies in the US also enhance the adoption of these advanced therapies.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2567
Recent Developments:
• In May 2024, Novartis announced an agreement to acquire Mariana Oncology, a preclinical-stage biotech firm based in Watertown, Massachusetts, focused on novel radioligand therapies (RLTs) for cancers with high unmet needs. This acquisition enhances Novartis' RLT pipeline and expands its research infrastructure, including programs targeting solid tumors like breast, prostate, and lung cancer, notably the actinium-based candidate MC-339 for small cell lung cancer.
• In April 2024, Curium agreed to acquire Eczacıbaşı-Monrol Nuclear Product Co. from Eczacıbaşı Holding and Bozlu Group. This acquisition will enhance Curium's geographic reach and increase its lutetium-177 (Lu-177) manufacturing capacity, meeting growing demand and advancing its radionuclide and radiopharmaceutical development for diagnostic and therapeutic uses.
Segmentation of Radionuclide Drug Conjugates (RDCs) Market-
By Type:
• Antibody Radionuclide Conjugates (ARC)
• Peptide Radionuclide Conjugates (PRC)
• Small Molecular Radionuclide Conjugates (SMRC)
By Disease Indication:
• Neuroendocrine Tumors
• Prostate Cancer
• Renal Cell
• Carcinoma
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2567
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radionuclide Drug Conjugates (RDCs) Market Top Companies Study - Telix Pharmaceuticals Limited, Grand Pharma, Bayer AG, Novartis AG, Lantheus. here
News-ID: 3775139 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd

Biocides Market Latest Trends and Growth Factors Analysis 2024 to 2031
"Biocides Market" in terms of revenue was estimated to be worth $11.57 billion in 2023 and is poised to reach $16.83 billion by 2031, growing at a CAGR of 4.91% from 2024 to 2031, according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1637
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biocides Market are:
• Growing Awareness of Hygiene and…

Beneficial Insects Market Current Scenario with Future Trends Analysis to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Beneficial Insects Market Size, Share & Trends Analysis Report By Application (Crop protection, Crop production), Type (Predators, Parasitoids, Pathogens, and Pollinators), Crop Type (Fruits & Vegetables, Flowers & Ornamentals, and Grains & Pulses), Region, Market Outlook And Industry Analysis 2031"
The global Beneficial Insects market is estimated to reach over USD 2.18 billion by 2031, exhibiting…

Avocado Puree Market Current Scenario with Future Trends Analysis to 2031
The global avocado puree market is estimated to reach over USD 755.03 million by 2031, exhibiting a CAGR of 5.18% during the forecast period.
Fresh avocados mashed, puréed, pressed, or sieved into a creamy slurry or paste consistency are used to make avocado purees. Avocado purees make mixed fruit drinks, infant food, and guacamole. Avocado puree market revenue is predicted to increase at a high CAGR, driven by millennials' phenomenal demand…

Automotive Lead Acid Battery Market Latest Trends and Growth Factors Analysis 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Automotive Lead Acid Battery Market Size, Share & Trends Analysis Report By Product (SLI and Micro-Hybrid Batteries), Type (Flooded, Enhanced Flooded, and VRLA), Customer Segment (OEM and Aftermarket), End User (Passenger Car, Light Commercial Vehicles, Heavy Commercial Vehicles, Two-Wheeler, and Three-Wheeler), and Application (Hybrid Vehicles, Electric Vehicles, Light Motor Vehicles, and Heavy Motor Vehicles)- Market…
More Releases for RDC
Refrigerated Display Cases (RDC) Glasses Market 2022 | Detailed Report
The Refrigerated Display Cases (RDC) Glasses report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Refrigerated Display Cases (RDC) Glasses…
Market Survey on Refrigerated Display Cases (RDC) Glasses – Innovations & Comp …
The intense rivalry between local and international vendors has kept the global refrigerated display case (RDC) glasses market fragmented, states a new research study by Transparency Market Research (TMR). Currently, the leading players are competing on the basis of technology. However, they are likely to focus more on developing their distribution channels in the years to come. Beverage-Air Corp., Hussman International, AHT Cooling Systems GmbH, ISA Italy S.r.l., Metalfrio Solutions…
Two JMA Pilani NCC Cadets selected for Republic Day Camp RDC
NCC (National Cadet Corps) is a national organization which has helped in inculcation in the cadets a spirits of courage, confidence, self-reliance, selfless service, a feeling of patriotism, faith in oneself, power of thought and adjustment which are essential to make the youth disciplined and dutiful.
NCC came into being by an Act of the Parliament Act No. XXXI of 1948 designated 'The National Cadet Corps Act 1948'. This Act with…
Refrigerated Display Cases (RDC) Glasses: Technological Advancements to Boost Ma …
The intense rivalry between local and international vendors has kept the global refrigerated display case (RDC) glasses market fragmented, states a new research study by Transparency Market Research (TMR). Currently, the leading players are competing on the basis of technology.
However, they are likely to focus more on developing their distribution channels in the years to come. Beverage-Air Corp., Hussman International, AHT Cooling Systems GmbH, ISA Italy S.r.l., Metalfrio Solutions S.A.,…
Refrigerated Display Cases (RDC) Glasses Market - High Price Associated to RDC G …
The intense rivalry between local and international vendors has kept the global refrigerated display case (RDC) glasses market fragmented, states a new research study by Transparency Market Research (TMR). Currently, the leading players are competing on the basis of technology. However, they are likely to focus more on developing their distribution channels in the years to come. Beverage-Air Corp., Hussman International, AHT Cooling Systems GmbH, ISA Italy S.r.l., Metalfrio Solutions…
Refrigerated Display Cases (RDC) Glasses Market Size to Observe Steady Growth
Presence of numerous manufacturers – local and global – makes competition in the global refrigerated display cases (RDC) glasses market intense and the landscape fragmented. The manufacturers mostly compete on the basis of technology. From glass makers, glass coating providers, and door assemblers to retrofitters, the companies in the market are leveraging various strategies to boost their positions. Some of them are mergers and acquisitions, competitive pricing, and new service…